Area of research
Rheumatology · Psychiatry and Mental health
Research interest
Research interests include Fibromyalgia and Chronic Fatigue Syndrome Research, Rheumatoid Arthritis Research and Therapies, Musculoskeletal pain and rehabilitation, and Systemic Lupus Erythematosus Research.
Neuroinflammatory and Immunological Aspects of Fibromyalgia.
Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.
The Relationship Between Patient-Reported Quality of Life and Physician-Derived Clinical Outcomes in Rheumatoid Arthritis in the Australian OPAL Dataset.
Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia.
Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings.
Bone and entheseal targets for growth factors in diffuse idiopathic skeletal hyperostosis.
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia
Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL dataset.
Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set.
Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia.
Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset.
Nociplastic pain: towards an understanding of prevalent pain conditions
Central sensitivity and fibromyalgia.
Fibromyalgia and psoriatic arthritis: Partners together.
Key Milestones Contributing to the Understanding of the Mechanisms Underlying Fibromyalgia.
Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia.
Chronic pain syndromes: overlapping phenotypes with common mechanisms.